Parkinson's Digest
  • All
  • Research
  • Trials
  • News
Pathophysiology of Neuronal Oscillations Within Subthalamo-cortical Loops in Parkinson's Disease
Trial N/A Completed May 6, 2026
Closed-loop TMS for Tremor
Trial N/A Recruiting May 6, 2026
The Use of 3D Printing Technology in Rehabilitation for Adults Living With Neurological Conditions: Scoping Review.
Research JMIR rehabilitation and assistive technologies May 6, 2026
Risk of Alzheimer Disease and Other Dementias in Patients With Parkinson Disease: A Nationwide Cohort Study.
Research Alzheimer disease and associated disorders May 6, 2026
Validation of remote multimodal AI screening for Parkinson disease across diverse settings.
Research Communications medicine May 6, 2026
Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders
Trial N/A Recruiting May 5, 2026
Functional Neuroimaging in Parkinson's Disease
Trial N/A Completed May 5, 2026
Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease
Trial Phase 3 Completed May 5, 2026
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improving Depressive Symptoms in Patients With Parkinson's Disease
Trial N/A Enrolling by invitation May 5, 2026
Effects of RAS on Gait in PD Patients With DBS
Trial N/A Recruiting May 5, 2026
In Vivo Noradrenergic System and Aging
Trial N/A Not yet recruiting May 5, 2026
Combined Deep Brain Stimulation in Parkinson's Disease
Trial N/A Completed May 5, 2026
Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients? (ETPARK-REMED)
Trial N/A Completed May 5, 2026
A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound Subthalamotomy in Patients With Early-Stage Parkinson's Disease
Trial N/A Active, not recruiting May 5, 2026
Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting
Trial N/A Recruiting May 5, 2026
Nonclinical characterization of ACP-204, a novel selective serotonin receptor subtype 2A receptor inverse agonist.
Research The Journal of pharmacology and experimental therapeutics May 5, 2026
Age-Specific Parkinson Disease Risk in Gaucher Disease Type 1: Data From the ICGG Gaucher Registry.
Research Neurology May 5, 2026
Risk Is Not Destiny: Unmasked Penetrance of Parkinson Disease in Gaucher Disease.
Research Neurology May 5, 2026
Four innovations to bridge the evidence-practice gap in Parkinson's disease allied health guidelines.
Research Parkinsonism & related disorders May 5, 2026
Advances in sex-specific single-cell transcriptomic profiling in Parkinson's disease
News SAGE Publications: Journal of Parkinson’s Disease: Table of Contents May 4, 2026
Previous Next

Parkinson's Digest provides access to the latest Parkinson's disease news, research, and clinical trials.

Source Code

Created by Brian Gaudino. Data sourced from ClinicalTrials.gov, PubMed, and other public sources.

Parkinson's Digest is provided for informational and educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding medical decisions.

© 2026 Parkinson's Digest